An Open Label Study to Establish the Preferred Dose and to Assess Safety and Overall Response Rate of Avastin in Combination With Concomitant Thoracic Radiation and Chemotherapy (Cisplatin and Etoposide) in Locally Advanced Unresectable Non-Squamous Non-Small Cell Lung Cancer.
Phase of Trial: Phase I
Latest Information Update: 15 May 2015
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin; Etoposide
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Adverse reactions
- Sponsors Roche
- 23 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 May 2009 Planned end date changed from 1 Oct 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.
- 22 Oct 2008 New trial record.